Kinetics of cholinesterase inhibition by eptastigmine in man
- 1 July 1991
- journal article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 41 (1) , 83-84
- https://doi.org/10.1007/bf00280116
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Extraction of physostigmine from biologic fluids and analysis by liquid chromatography with electrochemical detectionJournal of Pharmacological Methods, 1990
- Effects of metrifonate, a long-acting cholinesterease inhibitor, in alzheimer disease: Report of an open trialDrug Development Research, 1990
- New analogs of physostigmine: Alternative drugs for Alzheimer's disease?Life Sciences, 1988
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- A long-lasting cholinesterase inhibitor affecting neural and behavioral processesPharmacology Biochemistry and Behavior, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Anticholinesterase activity of a new carbamate, heptylphysostigmine, in view of its use in patients with Alzheimer-type dementiaEuropean Journal of Biochemistry, 1986
- Physostigmine effects in Alzheimer's disease: Relationship to dementia severityLife Sciences, 1986
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinationsAnalytical Biochemistry, 1975